Press Release: Innovative Medicines Initiative (IMI): the Commission and the pharmaceutical industry launch second call for research proposal towards more efficient drug development methods

The Innovative Medicines Initiative (IMI) has officially launched its second Call for proposals. The public-private partnership between the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) is inviting research consortia to submit proposals for 9 scientific topics. The aim of the Call is to speed up the discovery and development of new medicines for diseases such as cancer and inflammatory and infectious diseases. IMI will also fund projects to improve data exchange between industry and the scientific community, an important aspect of knowledge management. The Commission's contribution to this Call of €76.8 million is expected to be at least matched by in-kind contributions from the member companies of EFPIA.